Skip to Content

ibr 140 mg (Imbruvica 140 mg)

Generic Name: ibrutinib

Pill with imprint ibr 140 mg is White, Capsule-shape and has been identified as Imbruvica 140 mg. It is supplied by Pharmacyclics Inc.

Imbruvica is used in the treatment of chronic lymphocytic leukemia; non-hodgkin's lymphoma; waldenström macroglobulinemia; mantle cell lymphoma; graft-versus-host disease (and more), and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ibr 140 mg

Imbruvica

Generic Name:
ibrutinib
Imprint:
ibr 140 mg
Strength:
140 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pharmacyclics Inc
National Drug Code (NDC):
57962-0140

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide